Here are five points:
1. Technology advancements in surgical equipment, an increased number of patients with neurological conditions, a rising aging population and an increase in research and development activities contribute to the growth of the global neurosurgery market.
2. Asia is expected to witness a high rate of growth in the neurosurgery market in the coming years, due to a growing awareness of neurological disorders and increased government funding for the market.
3. India, China and Japan will lead the market’s growth in Asia.
4. Costly equipment and strict reimbursement regulations serve as obstacles to the market’s growth.
5. Some key companies in the market include Codman & Shurtleff, Medtronic, B. Braun Melsungen, Styker, BrainLab, Integra LifeSciences and NeuroVista.
More articles on devices:
Globus Medical’s short position drops 0.6%: 4 points
Stryker to build 3-D printed device manufacturing facility: 6 notes
Spinal implants, devices market to grow at CAGR of 6% to 2020: 6 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
